- Home
- ACTG vs MGTX Comparison
ACTG vs MGTX Comparison
Compare ACTG & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- MGTX
- Stock Information
- Founded
- ACTG 1993
- MGTX 2015
- Country
- ACTG United States
- MGTX United States
- Employees
- ACTG N/A
- MGTX N/A
- Industry
- ACTG Multi-Sector Companies
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACTG Miscellaneous
- MGTX Health Care
- Exchange
- ACTG Nasdaq
- MGTX Nasdaq
- Market Cap
- ACTG 453.7M
- MGTX 411.4M
- IPO Year
- ACTG 1996
- MGTX N/A
- Fundamental
- Price
- ACTG $4.65
- MGTX $6.85
- Analyst Decision
- ACTG Strong Buy
- MGTX Strong Buy
- Analyst Count
- ACTG 1
- MGTX 2
- Target Price
- ACTG $7.00
- MGTX $22.50
- AVG Volume (30 Days)
- ACTG 267.6K
- MGTX 457.2K
- Earning Date
- ACTG 11-12-2024
- MGTX 11-12-2024
- Dividend Yield
- ACTG N/A
- MGTX N/A
- EPS Growth
- ACTG N/A
- MGTX N/A
- EPS
- ACTG 0.50
- MGTX N/A
- Revenue
- ACTG $152,553,000.00
- MGTX $8,122,000.00
- Revenue This Year
- ACTG N/A
- MGTX N/A
- Revenue Next Year
- ACTG $21.60
- MGTX $5,284.51
- P/E Ratio
- ACTG $9.41
- MGTX N/A
- Revenue Growth
- ACTG 195.04
- MGTX 26.87
- 52 Week Low
- ACTG $3.55
- MGTX $3.85
- 52 Week High
- ACTG $5.74
- MGTX $7.60
- Technical
- Relative Strength Index (RSI)
- ACTG 54.47
- MGTX 78.96
- Support Level
- ACTG $4.71
- MGTX $5.52
- Resistance Level
- ACTG $4.79
- MGTX $6.36
- Average True Range (ATR)
- ACTG 0.15
- MGTX 0.31
- MACD
- ACTG -0.00
- MGTX 0.06
- Stochastic Oscillator
- ACTG 39.22
- MGTX 99.46
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.